Adjuvant Global Health Technology Fund, L.P.

Insider Reports History

Location
New York, NY
Signature
Adjuvant Global Health Technology Fund, L.P., By: Adjuvant Capital GP, L.P., its sole general partner, By: Adjuvant Capital Management, L.L.C., its sole general partner, By: Kabeer Aziz, Secretary, /s/ Kabeer Aziz
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Adjuvant Global Health Technology Fund, L.P.:

Company Role Class Num Shares Value Price $ Report Date Ownership
AN2 Therapeutics, Inc. 10%+ Owner Common Stock 1,995,958 $38,150,941 $19.11 16 Jan 2024 Direct
AN2 Therapeutics, Inc. 10%+ Owner Common Stock 377,542 $7,216,376 $19.11 16 Jan 2024 By Adjuvant Global Health Technology Fund DE, L.P.

Insider Reports Filed by Adjuvant Global Health Technology Fund, L.P.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ANTX AN2 Therapeutics, Inc. 16 Jan 2024 2 -$1,965,000 4 10%+ Owner 18 Jan 2024, 18:18
ANTX AN2 Therapeutics, Inc. 14 Nov 2023 2 -$29,224 4 10%+ Owner 16 Nov 2023, 18:59
ANTX AN2 Therapeutics, Inc. 29 Sep 2023 4 -$1,704,513 4 10%+ Owner 03 Oct 2023, 19:13
ANTX AN2 Therapeutics, Inc. 27 Sep 2023 4 -$150,708 4 10%+ Owner 29 Sep 2023, 17:41
ANTX AN2 Therapeutics, Inc. 23 Aug 2023 2 -$6,400 4 10%+ Owner 15 Sep 2023, 17:17
ANTX AN2 Therapeutics, Inc. 23 Aug 2023 4 -$114,484 4 10%+ Owner 08 Sep 2023, 16:59
ANTX AN2 Therapeutics, Inc. 23 Aug 2023 2 -$6,400 4 10%+ Owner 25 Aug 2023, 16:31
ANTX AN2 Therapeutics, Inc. 06 Jun 2022 2 $0 4 10%+ Owner 24 Jun 2022, 17:06
ANTX AN2 Therapeutics, Inc. 29 Mar 2022 9 +$2,499,990 4/A 10%+ Owner 24 Jun 2022, 16:51
ANTX AN2 Therapeutics, Inc. 24 Mar 2022 0 $0 3/A 10%+ Owner 24 Jun 2022, 16:48